Genoa Pharmaceuticals — a biopharmaceutical company working on treatments for respiratory diseases — was operating under the radar just last week. But the company sprung into the limelight Monday with a… Read More
Bruce Montgomery, one of Seattle’s longtime biotech veterans, was among the investors that participated in a $10 million funding round for M3 Biotechnology, a startup focused on fighting brain ailments,… Read More
It has been a good week for the Seattle life sciences community. On Monday, Seattle genomics tool maker NanoString Technologies filed for an initial public offering that could raise up… Read More
Cardeas Pharma, a biotechnology company led by Seattle biotech entrepreneur Bruce Montgomery, has reeled in $5 million in venture financing from Novo Ventures, Avalon Ventures, WRF Capital and others, reports Xconomy.… Read More